Cladribine

Key facts

Active substance
Cladribine
Therapeutic area
Neurology
Decision number
P/101/2009
PIP number
Cladribine
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Multiple Sclerosis
Route(s) of administration
Oral use
Contact for public enquiries
KGaA
E-mail: service@merck.de
Country: Germany
Phone: +49 6151720
Fax: +49 6151722000
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

Topics

How useful was this page?

Add your rating